Production and possible reduction of greenhouse gases produced during GI endoscopy activity: a systematic review of available literature.
endoscopy
environmental health
gastrointestinal pathology
Journal
Gut
ISSN: 1468-3288
Titre abrégé: Gut
Pays: England
ID NLM: 2985108R
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
27
07
2022
accepted:
29
10
2022
pubmed:
16
12
2022
medline:
10
2
2023
entrez:
15
12
2022
Statut:
ppublish
Résumé
Greenhouse gases (GHGs) that trap heat in the atmosphere are composed of carbon dioxide (CO The GI endoscopy carbon cycle was evaluated at preprocedural, intraprocedural and postprocedural levels. We performed a systematic literature search of articles published on these issues until 30 June 2022 and discussed these available data on endoscopy unit GHG carbon cycle, barriers to reduce GHG emissions and potential solutions. The inclusion criteria were any full-text articles (observational, clinical trials, brief communications, case series and editorials) reporting waste generation from GI endoscopy. Abstracts, news articles and conference proceedings were excluded. Our search yielded 393 records in PubMed, 1708 in Embase and 24 in Google Scholar. After application of inclusion and exclusion factors, we focused on 9 fulllength articles in detail, only 3 of them were cross-sectional studies (all from the USA), the others reviews or position statements. Therefore, the quality of the studies could not be assessed due to heterogeneity in definitions and amount of emissions. Recognition of carbon emissions generated by GI endoscopy activity is critical. Although multiple limitations exists for quantification of these emission, there is an urgent need for collecting proper data as well as examining novel methods for reduction of these emissions for a sustainable endoscopic practices in the future.
Sections du résumé
BACKGROUND AND AIMS
Greenhouse gases (GHGs) that trap heat in the atmosphere are composed of carbon dioxide (CO
DESIGN
The GI endoscopy carbon cycle was evaluated at preprocedural, intraprocedural and postprocedural levels. We performed a systematic literature search of articles published on these issues until 30 June 2022 and discussed these available data on endoscopy unit GHG carbon cycle, barriers to reduce GHG emissions and potential solutions. The inclusion criteria were any full-text articles (observational, clinical trials, brief communications, case series and editorials) reporting waste generation from GI endoscopy. Abstracts, news articles and conference proceedings were excluded.
RESULTS
Our search yielded 393 records in PubMed, 1708 in Embase and 24 in Google Scholar. After application of inclusion and exclusion factors, we focused on 9 fulllength articles in detail, only 3 of them were cross-sectional studies (all from the USA), the others reviews or position statements. Therefore, the quality of the studies could not be assessed due to heterogeneity in definitions and amount of emissions.
CONCLUSIONS
Recognition of carbon emissions generated by GI endoscopy activity is critical. Although multiple limitations exists for quantification of these emission, there is an urgent need for collecting proper data as well as examining novel methods for reduction of these emissions for a sustainable endoscopic practices in the future.
Identifiants
pubmed: 36522150
pii: gutjnl-2022-328369
doi: 10.1136/gutjnl-2022-328369
doi:
Substances chimiques
Greenhouse Gases
0
Gases
0
Nitrous Oxide
K50XQU1029
Carbon Dioxide
142M471B3J
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
493-500Informations de copyright
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: AP, MJB, IP, AR, DNR, HT, DKR, CH: none. MD: Grant support: Intercept Pharma. PS: Consultant-Bausch, Boston Scientific Corporation, CDx Labs, Covidien LP, Exact Sciences, Fujifilm Medical Systems USA, Inc, Lucid, Lumendi, Medtronic, Phathom, Olympus, Takeda, Samsung BioepisGrant/Contract-Cosmo Pharmaceuticals, Covidien, Docbot, ERBE USA, Inc, Fujifilm Holdings America Corporation, Ironwood Pharmaceuticals, Inc., Medtronic USA, Inc.